Iain Ross

Iain Ross

Amministratore Delegato presso SILENCE THERAPEUTICS PLC

Patrimonio netto: 166 914 $ in data 31/05/2026

72 anni
Health Technology
Commercial Services
Consumer Services

Profilo

Iain Gladstone Ross founded Biomer Technology Ltd. in 2003, where he is working as Director from 2003.
Mr. Ross also currently works at Silence Therapeutics Plc, as Chairman & Chief Executive Officer from 2025, ReNeuron Group Plc, as Executive Chairman from 2023, Novagen Ltd., as Chairman, and various other companies.
Mr. Ross also formerly worked at LNRS Data Services Ltd. (Surrey), as Chief Executive Officer, Sandoz AG, as Chairman & Chief Executive Officer, Lonza Biologics Plc, as Chief Executive Officer, and various other companies.
Mr. Ross received his undergraduate degree from the University of London.

Partecipazioni note in società pubbliche

SocietàDataNumero di azioniValutazioneData di valutazione
31/03/2026 39.942 ( 0,03% ) 71 896 $ 30/11/2025
10/11/2025 23.333.333 ( 0,54% ) 58 100 $ 31/05/2026
21/04/2026 2.107.209 ( 0,25% ) 36 918 $ 31/05/2026

Posizioni attive di Iain Ross

SocietàPosizioneInizio
SILENCE THERAPEUTICS PLC Amministratore Delegato 14/12/2025
RENEURON GROUP PLC Presidente 01/07/2021
TERN PLC Direttore/Membro del Consiglio 29/10/2024
OXFORD BIODYNAMICS PLC Presidente 31/01/2025
Presidente -
Fondatore 01/01/2003
Gladstone Partners Ltd.
Direttore/Membro del Consiglio -

Precedenti posizioni note di Iain Ross

SocietàPosizioneFine
ADALTA LIMITED Direttore/Membro del Consiglio 30/06/2025
BIVICTRIX THERAPEUTICS PLC Presidente 06/01/2023
░░░░░ ░░░░░░░░░░░░ ░░░░░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░ ░░░░░░░░░░░░░░░░ ░░░ ░░░░░░░░░ ░░░░░░░░░░
░░░░ ░░░░░░ ░░░ ░░░░░░░░░░░░░░ ░░░░░░░░ ░░░░░░░░░░
Vedi nel dettaglio l'esperienza di Iain Ross

Formazione di Iain Ross

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Relazioni

56

Relazioni di 1° grado

44

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Società collegate

Aziende private44

Health Technology

Health Technology

Health Technology

Non-Energy Minerals

Technology Services

Health Technology

Finance

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Consumer Services

Commercial Services

Health Technology

Consumer Services

Producer Manufacturing

Consumer Services

Process Industries

Health Technology

Health Technology

Health Technology

Commercial Services

Health Technology

Commercial Services

Health Technology

Health Technology

Health Technology

Health Technology

Health Technology

Gladstone Partners Ltd.

Tissue Therapies Europe Ltd.

Yellowcross Ltd.

Health Technology

Health Technology

Consumer Services

Process Industries

Health Technology

Health Technology

- 40%: I migliori strumenti riservati agli abbonati per individuare le opportunità di investimento di domani.
g
:
:
ENTRA ORA